These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

623 related items for PubMed ID: 27230555

  • 1. Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus.
    Feng X, Chen W, Xiao L, Gu F, Huang J, Tsao BP, Sun L.
    Lupus; 2017 Jan; 26(1):62-72. PubMed ID: 27230555
    [Abstract] [Full Text] [Related]

  • 2. New insights into the role and mechanism of macrophage migration inhibitory factor in steroid-resistant patients with systemic lupus erythematosus.
    Wang FF, Zhu LA, Zou YQ, Zheng H, Wilson A, Yang CD, Shen N, Wallace DJ, Weisman MH, Chen SL, Lu LJ.
    Arthritis Res Ther; 2012 May 02; 14(3):R103. PubMed ID: 22551315
    [Abstract] [Full Text] [Related]

  • 3. [The relationship between mRNA level of glucocorticoid receptor α, heat shock protein 90, protein level of macrophage migration inhibitory factor and glucocorticoid resistance in systemic lupus erythematosus].
    Guan Y, Zhang Y, Fang M, Guan J, Sun X, Zhang J.
    Zhonghua Nei Ke Za Zhi; 2015 Nov 02; 54(11):922-6. PubMed ID: 26759210
    [Abstract] [Full Text] [Related]

  • 4. Identification of Cyclin-Dependent Kinase 1 as a Novel Regulator of Type I Interferon Signaling in Systemic Lupus Erythematosus.
    Wu L, Qin Y, Xia S, Dai M, Han X, Wu Y, Zhang X, Ma J, Wang Y, Tang Y, Liu Z, Zhu W, Jallal B, Yao Y, Qu B, Shen N.
    Arthritis Rheumatol; 2016 May 02; 68(5):1222-32. PubMed ID: 26663909
    [Abstract] [Full Text] [Related]

  • 5. [The expression of migration inhibitory factor in peripheral blood mononuclear cell and its correlation with disease activity in systemic lupus erythematosus].
    Chen WY, Li GR, Fang F, Yang X, He XS, Zhou FY, Yu XQ.
    Zhonghua Nei Ke Za Zhi; 2004 Aug 02; 43(8):572-5. PubMed ID: 15355659
    [Abstract] [Full Text] [Related]

  • 6. Elevated STAT1 expression but not phosphorylation in lupus B cells correlates with disease activity and increased plasmablast susceptibility.
    Aue A, Szelinski F, Weißenberg SY, Wiedemann A, Rose T, Lino AC, Dörner T.
    Rheumatology (Oxford); 2020 Nov 01; 59(11):3435-3442. PubMed ID: 32357246
    [Abstract] [Full Text] [Related]

  • 7. Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells.
    Karonitsch T, Feierl E, Steiner CW, Dalwigk K, Korb A, Binder N, Rapp A, Steiner G, Scheinecker C, Smolen J, Aringer M.
    Arthritis Rheum; 2009 May 01; 60(5):1463-71. PubMed ID: 19404947
    [Abstract] [Full Text] [Related]

  • 8. MIF promotes a differential Th1/Th2/Th17 inflammatory response in human primary cell cultures: Predominance of Th17 cytokine profile in PBMC from healthy subjects and increase of IL-6 and TNF-α in PBMC from active SLE patients.
    De la Cruz-Mosso U, García-Iglesias T, Bucala R, Estrada-García I, González-López L, Cerpa-Cruz S, Parra-Rojas I, Gámez-Nava JI, Pérez-Guerrero EE, Muñoz-Valle JF.
    Cell Immunol; 2018 Feb 01; 324():42-49. PubMed ID: 29397904
    [Abstract] [Full Text] [Related]

  • 9. PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus.
    Wang Y, Ewart D, Crabtree JN, Yamamoto A, Baechler EC, Fazeli P, Peterson EJ.
    Arthritis Rheumatol; 2015 Sep 01; 67(9):2403-14. PubMed ID: 26018863
    [Abstract] [Full Text] [Related]

  • 10. MiRNA Regulation of MIF in SLE and Attenuation of Murine Lupus Nephritis With miR-654.
    Tu Y, Guo R, Li J, Wang S, Leng L, Deng J, Bucala R, Lu L.
    Front Immunol; 2019 Sep 01; 10():2229. PubMed ID: 31608058
    [Abstract] [Full Text] [Related]

  • 11. High Interferon Signature Leads to Increased STAT1/3/5 Phosphorylation in PBMCs From SLE Patients by Single Cell Mass Cytometry.
    Yiu G, Rasmussen TK, Tsai BL, Diep VK, Haddon DJ, Tsoi J, Miller GD, Comin-Anduix B, Deleuran B, Crooks GM, Utz PJ.
    Front Immunol; 2022 Sep 01; 13():833636. PubMed ID: 35185925
    [Abstract] [Full Text] [Related]

  • 12. Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies.
    Hua J, Kirou K, Lee C, Crow MK.
    Arthritis Rheum; 2006 Jun 01; 54(6):1906-16. PubMed ID: 16736505
    [Abstract] [Full Text] [Related]

  • 13. Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus.
    Kirou KA, Lee C, George S, Louca K, Papagiannis IG, Peterson MG, Ly N, Woodward RN, Fry KE, Lau AY, Prentice JG, Wohlgemuth JG, Crow MK.
    Arthritis Rheum; 2004 Dec 01; 50(12):3958-67. PubMed ID: 15593221
    [Abstract] [Full Text] [Related]

  • 14. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
    Bodewes ILA, Huijser E, van Helden-Meeuwsen CG, Tas L, Huizinga R, Dalm VASH, van Hagen PM, Groot N, Kamphuis S, van Daele PLA, Versnel MA.
    J Autoimmun; 2018 Jul 01; 91():97-102. PubMed ID: 29673738
    [Abstract] [Full Text] [Related]

  • 15. Characterization of 5C11-positive activated interferon-producing cells in patients with systemic lupus erythematosus.
    Ohshima M, Kanda H, Kubo K, Yonezumi-Hayashi A, Tateishi S, Yamamoto K.
    Lupus; 2013 Jan 01; 22(1):44-51. PubMed ID: 23087259
    [Abstract] [Full Text] [Related]

  • 16. Antimalarial drugs inhibit IFNα-enhanced TNFα and STAT4 expression in monocytes: implication for systemic lupus erythematosus.
    López P, Rodríguez-Carrio J, Suárez A.
    Cytokine; 2014 May 01; 67(1):13-20. PubMed ID: 24680477
    [Abstract] [Full Text] [Related]

  • 17. Interferon-α priming promotes lipid uptake and macrophage-derived foam cell formation: a novel link between interferon-α and atherosclerosis in lupus.
    Li J, Fu Q, Cui H, Qu B, Pan W, Shen N, Bao C.
    Arthritis Rheum; 2011 Feb 01; 63(2):492-502. PubMed ID: 21280004
    [Abstract] [Full Text] [Related]

  • 18. Enhanced Inflammasome Activity in Systemic Lupus Erythematosus Is Mediated via Type I Interferon-Induced Up-Regulation of Interferon Regulatory Factor 1.
    Liu J, Berthier CC, Kahlenberg JM.
    Arthritis Rheumatol; 2017 Sep 01; 69(9):1840-1849. PubMed ID: 28564495
    [Abstract] [Full Text] [Related]

  • 19. Macrophage migration inhibitory factor in systemic lupus erythematosus.
    Foote A, Briganti EM, Kipen Y, Santos L, Leech M, Morand EF.
    J Rheumatol; 2004 Feb 01; 31(2):268-73. PubMed ID: 14760795
    [Abstract] [Full Text] [Related]

  • 20. Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.
    Yao Y, Richman L, Higgs BW, Morehouse CA, de los Reyes M, Brohawn P, Zhang J, White B, Coyle AJ, Kiener PA, Jallal B.
    Arthritis Rheum; 2009 Jun 01; 60(6):1785-96. PubMed ID: 19479852
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.